342 related articles for article (PubMed ID: 16199699)
21. Long-term outcome of speech and language in children after corrective surgery for cyanotic or acyanotic cardiac defects in infancy.
Hövels-Gürich HH; Bauer SB; Schnitker R; Willmes-von Hinckeldey K; Messmer BJ; Seghaye MC; Huber W
Eur J Paediatr Neurol; 2008 Sep; 12(5):378-86. PubMed ID: 18221897
[TBL] [Abstract][Full Text] [Related]
22. A longitudinal perspective on neurodevelopmental outcome after infant cardiac transplantation.
Freier MC; Babikian T; Pivonka J; Burley Aaen T; Gardner JM; Baum M; Bailey LL; Chinnock RE
J Heart Lung Transplant; 2004 Jul; 23(7):857-64. PubMed ID: 15261181
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
[TBL] [Abstract][Full Text] [Related]
24. Improved neurodevelopmental outcomes following long-term high-dose oral acyclovir therapy in infants with central nervous system and disseminated herpes simplex disease.
Tiffany KF; Benjamin DK; Palasanthiran P; O'Donnell K; Gutman LT
J Perinatol; 2005 Mar; 25(3):156-61. PubMed ID: 15605069
[TBL] [Abstract][Full Text] [Related]
25. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997.
Mikkola K; Ritari N; Tommiska V; Salokorpi T; Lehtonen L; Tammela O; Pääkkönen L; Olsen P; Korkman M; Fellman V
Pediatrics; 2005 Dec; 116(6):1391-400. PubMed ID: 16322163
[TBL] [Abstract][Full Text] [Related]
26. The role of early fine and gross motor development on later motor and cognitive ability.
Piek JP; Dawson L; Smith LM; Gasson N
Hum Mov Sci; 2008 Oct; 27(5):668-81. PubMed ID: 18242747
[TBL] [Abstract][Full Text] [Related]
27. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
[TBL] [Abstract][Full Text] [Related]
28. Forty-one year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: cerebellar atrophy, multiphasic relapses, and response to IVIG.
Pranzatelli MR; Tate ED; Kinsbourne M; Caviness VS; Mishra B
Mov Disord; 2002 Nov; 17(6):1387-90. PubMed ID: 12465092
[TBL] [Abstract][Full Text] [Related]
29. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
30. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH.
Selva KA; Harper A; Downs A; Blasco PA; Lafranchi SH
J Pediatr; 2005 Dec; 147(6):775-80. PubMed ID: 16356430
[TBL] [Abstract][Full Text] [Related]
31. [Ataxia-opsoclonus-myoclonus syndrome].
Pinsard N; Pons-Cerdan C; Mancini J; Livet MO; Bernard R
Sem Hop; 1981 Mar 8-15; 57(9-10):488-94. PubMed ID: 6261394
[TBL] [Abstract][Full Text] [Related]
32. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
Matthay KK; Blaes F; Hero B; Plantaz D; De Alarcon P; Mitchell WG; Pike M; Pistoia V
Cancer Lett; 2005 Oct; 228(1-2):275-82. PubMed ID: 15922508
[TBL] [Abstract][Full Text] [Related]
33. Correspondence: treatment of the neuroblastoma-associated opsoclonus-myoclonus-ataxia (OMA) syndrome with high-dose methylprednisolone.
Emir S; Akyüz C; Büyükpamukçu M
Med Pediatr Oncol; 2003 Feb; 40(2):139. PubMed ID: 12461808
[No Abstract] [Full Text] [Related]
34. Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia.
Turkel SB; Brumm VL; Mitchell WG; Tavare CJ
J Neuropsychiatry Clin Neurosci; 2006; 18(2):239-41. PubMed ID: 16720803
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of ten children with opsoclonus-myoclonus syndrome.
Klein A; Schmitt B; Boltshauser E
Eur J Pediatr; 2007 Apr; 166(4):359-63. PubMed ID: 17089089
[TBL] [Abstract][Full Text] [Related]
36. Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses.
Wilken B; Baumann M; Bien CG; Hero B; Rostasy K; Hanefeld F
Eur J Paediatr Neurol; 2008 Jan; 12(1):51-5. PubMed ID: 17625938
[TBL] [Abstract][Full Text] [Related]
37. Child neurodevelopmental outcome and maternal occupational exposure to solvents.
Laslo-Baker D; Barrera M; Knittel-Keren D; Kozer E; Wolpin J; Khattak S; Hackman R; Rovet J; Koren G
Arch Pediatr Adolesc Med; 2004 Oct; 158(10):956-61. PubMed ID: 15466682
[TBL] [Abstract][Full Text] [Related]
38. Measuring functional skills in preschool children at risk for neurodevelopmental disabilities.
Msall ME
Ment Retard Dev Disabil Res Rev; 2005; 11(3):263-73. PubMed ID: 16161097
[TBL] [Abstract][Full Text] [Related]
39. Amygdalar volume and behavioral development in autism.
Munson J; Dawson G; Abbott R; Faja S; Webb SJ; Friedman SD; Shaw D; Artru A; Dager SR
Arch Gen Psychiatry; 2006 Jun; 63(6):686-93. PubMed ID: 16754842
[TBL] [Abstract][Full Text] [Related]
40. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
